EichorEICHOR
Location: Rogers Synced from ClinicalTrials.gov · August 07, 2026

Clinical studies recruiting near Rogers

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · Highlands Oncology Group, PA · Pfizer · NCT07028853A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
Phase 3 · Woodland Research Northwest · Bristol-Myers Squibb · NCT06929273Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Phase 1/Phase 2 · Highlands Oncology Group, PA · Pfizer · NCT07421700A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previ
Phase 3 · Highlands Oncology Group, PA · Pfizer · NCT07144280Encouraging Abstinence Behavior in a Drug Epidemic: Optimizing Dynamic Incentives
NA · Wake Forest University Health Sciences · NCT04927143A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
Phase 3 · Highlands Oncology · Pfizer · NCT06629779Non-invasive Cranial Electrical Stimulation for Mealtime Anxiety in Adults With Eating Disorders
NA · Rogers Behavioral Health · NCT07017322Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Bipolar I Disorder
Phase 2 · Woodland Research Northwest · Rapport Therapeutics Inc. · NCT07046494Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder
Phase 2 · Clinical Site · Intra-Cellular Therapies, Inc. · NCT06701903Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Antica
Phase 1/Phase 2 · Highlands Oncology Group · Pfizer · NCT07227415A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
Phase 3 · Woodland Research Northwest · Xenon Pharmaceuticals Inc. · NCT06775379A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Trea
Phase 2 · Woodland Research Northwest · atai Therapeutics, Inc. · NCT06524830Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
Phase 2 · Highlands Oncology Group - Rogers · SWOG Cancer Research Network · NCT05633615Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Inva
Phase 2 · Highlands Oncology Group - Rogers · National Cancer Institute (NCI) · NCT07061964A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Phase 1 · Highlands Oncology Group · Seagen, a wholly owned subsidiary of Pfizer · NCT04389632Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult
Phase 3 · Highlands Oncology Group · Pfizer · NCT07222800Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
Phase 3 · Reviva site · Reviva Pharmaceuticals · NCT05184335Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With
Phase 3 · Highlands Oncology Group - Rogers · National Cancer Institute (NCI) · NCT07198074Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer
Phase 1/Phase 2 · Highlands Oncology Group, PA · Pfizer · NCT07227298Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Remo
Phase 2/Phase 3 · Highlands Oncology Group - Rogers · National Cancer Institute (NCI) · NCT05987241ADCE-T02, a Tissue Factor Targeted Antibody-Drug Conjugate, in Patients With Selected Advanced Solid Tumours
Phase 1 · Highlands Oncology Group · Adcendo ApS · NCT06597721C-Brace Prospective Registry
Phase N/A · Jonesboro P&O x Ottobock.care · Otto Bock Healthcare Products GmbH · NCT04640584Candida Therapeutic Vaccine in Head and Neck Cancer Patients to Reduce Recurrence
Phase 2 · Highlands Oncology Group, PA · University of Arkansas · NCT05952934A Trial of the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants With Schizophrenia
Phase 3 · Woodland Research Northwest Site · Otsuka Pharmaceutical Development & Commercialization, Inc. · NCT06894212Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy T
Phase 2 · Highlands Oncology Group - Rogers · National Cancer Institute (NCI) · NCT06770582Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adul
Phase 2/Phase 3 · Highlands Oncology Group · Pfizer · NCT07226999BostonGene and Exigent Genomic INsight Study
Phase N/A · Highlands Oncology Group · BostonGene · NCT06272864Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
Phase 3 · Highlands Oncology Group - Rogers · National Cancer Institute (NCI) · NCT06337318A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participant
Phase 3 · NW Arkansas Clinical Trials Center /ID# 254311 · AbbVie · NCT05889182A Study of Brenipatide in Adults Who Quit Smoking Cigarettes and Want to Avoid Relapse
Phase 2 · Woodland Research Northwest · Eli Lilly and Company · NCT07223840
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.